The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Raskurazhev A.A.

Neurology Research Center, Moscow, Russia

Kuznetsova P.I.

Research Center of Neurology, 80 Volokolamskoe shosse, Moscow, Russian Federation, 125367

Aspirin: the legend continues

Authors:

Tanashyan M.M., Raskurazhev A.A., Kuznetsova P.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2018;21(5): 124‑129

DOI: 10.17116/profmed201821051124

Views: 7442

Downloaded: 161

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Tanashyan MM, Raskurazhev AA, Kuznetsova PI. Aspirin: the legend continues. Russian Journal of Preventive Medicine. 2018;21(5):124‑129. (In Russ.)
https://doi.org/10.17116/profmed201821051124

 
МСФ на ЯМ
Close metadata
Recommended articles:
Gender differences in mental and beha­vioural diso­rders as an impo­rtant stage of cardiovascular diseases prevention in young people. Russian Journal of Preventive Medi­cine. 2024;(3):66-71
Colo­rectal cancer: inci­dence, risk factors, and screening. Russian Journal of Preventive Medi­cine. 2024;(3):93-97
Possibilities of cardiometabolic diseases prevention in women with pregnancy adve­rse outcomes in medi­cal history. Russian Journal of Preventive Medi­cine. 2024;(3):98-103
Mortality from cere­brovascular diseases in the Russian Fede­ration before and during the COVID-19 epidemy: regional differences. Russian Journal of Preventive Medi­cine. 2024;(4):12-17
Effe­ctiveness of body weight control using remote digi­tal technologies in various orga­nizational models of primary health care. Medi­cal Technologies. Asse­ssment and Choice. 2024;(1):26-36
The rela­tionship between the deve­lopment of post-stroke cognitive impairment and changes in the coagulation component of hemo­stasis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):23-29
Primary prevention of computer game addi­ction in students of educational institutions. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):97-103
To the issue of early diagnosis of mali­gnant skin neoplasms during medi­cal check-ups. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):161-167
Rela­pse of primary mediastinal B-cell lymphoma with isolated central nervous system invo­lvement: risk factors and search for personalized therapy. P.A. Herzen Journal of Onco­logy. 2024;(2):39-45
Promising approaches to the pathogenetic therapy of amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21

This paper deals with the history of the discovery and use of acetylsalicylic acid (ASA) (aspirin), one of the most well-known drugs. It traces the development and use range expansion of aspirin, its role in the prevention and treatment of cardiovascular diseases. Particular emphasis is placed on the use of ASA in patients with cerebrovascular disorders.

Keywords:

acetylsalicylic acid
aspirin
cerebrovascular diseases
prevention

Authors:

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Raskurazhev A.A.

Neurology Research Center, Moscow, Russia

Kuznetsova P.I.

Research Center of Neurology, 80 Volokolamskoe shosse, Moscow, Russian Federation, 125367

List of references:

  1. Jack DB. One hundred years of aspirin. Lancet. 1997;350:437-439. https://doi.org/10.1016/S0140-6736(97)07087-6
  2. Stone E. An account of the success of the bark of the willow tree in the cure of agues. Philos Trans R Soc Lond. 1763;53:195-200. https://doi.org/10.1098/rstl.1763.0033
  3. Wick JY. Aspirin: a history, a love story. The Consultant Pharmacist. 2012;27(5):322-329. https://doi.org/10.4140/TCP.n.2012.322
  4. Leroux H. Discovery of salicine. J Chim Med. 1830;6:340-432.
  5. MacLagan T. The treatment of acute rheumatism by salicin and salicylic acid. Lancet. 1876;1:342-344. https://doi.org/10.1016/S0140-6736(02)46061-8
  6. Askwith R. How aspirin turned hero. Sunday Times (London).1998 Sep 13.
  7. Dreser H. Pharmakologisches uber aspirin (acetylsalicylsaure). Pflugers Arch. 1899;76:306-318. https://doi.org/10.1007/BF01662127
  8. Craven LL. Acetylsalicylic acid: possible preventive of coronary thrombosis. Ann West Med Surg. 1950;4:95-99.
  9. Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J. 1953;75:38-44.
  10. Craven LL. Prevention of coronary and cerebral thrombosis. Miss Valley Med J. 1956;78:213-215.
  11. Vane J, et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232-235. https://doi.org/10.1038/newbio231232a0
  12. Davi G, Patrono C. Platelet activation and atherothrombosis. The New England Journal of Medicine. 2007;24(357):2482-2494. https://doi.org/10.1056/NEJMra071014
  13. Tanashyan MM, Domashenko MA. Acetylsalicylic acid in the treatment and prevention of cerebrovascular diseases. Nervnye bolezni. 2012;1:13-17. (In Russ.)
  14. Domashenko MA, Maksimova MYu, Tanashyan MM. Acetylsalicylic acid in the treatment and prevention of cerebrovascular diseases. RMZh. 2011;30:1854-1858. (In Russ.)
  15. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160-236. https://doi.org/10.1161/STR.0000000000000024
  16. Meschia JF, Bushnell C, Bernadette BA, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MSV, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Dec;45(12):3754-832. https://doi.org/10.1161/STR.0000000000000046
  17. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. https://doi.org/10.1161/STR.0b013e318284056a
  18. Suslina ZA, Ionova VG, Demina EG. Sposob issledovaniya antiagregacionnogo dejstviya preparatov s pomoshch’yu opredeleniya agregacii trombocitov. Patent №2188419, 27.08.02. (In Russ.)
  19. Fan L, Cao J, Liu L, Li X, Hu G, Hu Y, Zhu B. Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease. Gerontology. 2013;59:122-131. https://doi.org/10.1159/000342489
  20. Khamidova ZM, Tanashyan MM, Shabalina AA, Kostyreva MV. Clinical and biochemical markers of resistance to acetylsalicylic acid in patients with progressive arteriosclerosis of brachiocephal arteries. Tromboz, gemostaz i reologiya. 2013;1(53):57-62. (In Russ.)
  21. Suslina ZA, Tanashyan MM, Domashenko MA. Resistance to antiplatelet drugs in patients with cerebrovascular disorders. Vestnik Rossijskoj akademii medicinskih nauk. 2011;7:3-8. (In Russ.)
  22. Kübler W, Darius H. Primäre Prävention der koronaren Herzkrankheit mit Aspirin. Z Kardiol. 2005;94(Suppl 3):iii66. https://doi.org/10.1007/s00392-005-1309-8
  23. Bode-Böger SM, Böger RH, Schubert M, Frölich JC. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects. Eur J Clin Pharmacol. 1998;54(9-10):707-714. https://doi.org/10.1007/s002280050539

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.